APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets ; volume:16 ; number:1 ; day:29 ; month:6 ; year:2024 ; pages:1-7 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (29.6.2024), 1-7, 12.2024
- Creator
-
Sirisi, Sònia
Sánchez-Aced, Érika
Belbin, Olivia
Lleó, Alberto
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-024-01504-w
- URN
-
urn:nbn:de:101:1-2409202100542.387792081312
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sirisi, Sònia
- Sánchez-Aced, Érika
- Belbin, Olivia
- Lleó, Alberto
- SpringerLink (Online service)
Other Objects (12)
Current understanding of metal ions in the pathogenesis of Alzheimer’s disease
Complement in the pathogenesis of Alzheimer’s disease
Krüppel-like factor 5 accelerates the pathogenesis of Alzheimer’s disease via BACE1-mediated APP processing
Innate immunity and inflammation in Alzheimer´s disease pathogenesis
Correction to: Complement in the pathogenesis of Alzheimer’s disease
Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
Current state of Alzheimer’s fluid biomarkers
GJA1 (connexin43) is a key regulator of Alzheimer’s disease pathogenesis
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Fluid biomarkers in Alzheimer’s disease – current concepts
Current understanding of metal ions in the pathogenesis of Alzheimer’s disease
Complement in the pathogenesis of Alzheimer’s disease
Krüppel-like factor 5 accelerates the pathogenesis of Alzheimer’s disease via BACE1-mediated APP processing
Innate immunity and inflammation in Alzheimer´s disease pathogenesis
Correction to: Complement in the pathogenesis of Alzheimer’s disease
Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
Current state of Alzheimer’s fluid biomarkers
GJA1 (connexin43) is a key regulator of Alzheimer’s disease pathogenesis
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Fluid biomarkers in Alzheimer’s disease – current concepts
Current understanding of metal ions in the pathogenesis of Alzheimer’s disease
Complement in the pathogenesis of Alzheimer’s disease
Krüppel-like factor 5 accelerates the pathogenesis of Alzheimer’s disease via BACE1-mediated APP processing
Innate immunity and inflammation in Alzheimer´s disease pathogenesis
Correction to: Complement in the pathogenesis of Alzheimer’s disease
Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
Current state of Alzheimer’s fluid biomarkers
GJA1 (connexin43) is a key regulator of Alzheimer’s disease pathogenesis
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments